Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1002/jca.21881

http://scihub22266oqcxt.onion/10.1002/jca.21881
suck pdf from google scholar
33544910!8014691!33544910
unlimited free pdf from europmc33544910    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33544910      J+Clin+Apher 2021 ; 36 (3): 470-482
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis #MMPMID33544910
  • Vegivinti CTR; Pederson JM; Saravu K; Gupta N; Evanson KW; Kamrowski S; Schmidt M; Barrett A; Trent H; Dibas M; Reierson NL; Mikoff N; Pisipati S; Joseph BA; Selvan PT; Dmytriw AA; Pulakurthi YS; Keesari PR; Sriram V; Chittajallu S; Brinjikji W; Katamreddy RR; Chibbar R; Davis AR; Malpe M; Mishra HK; Kallmes KM; Hassan AE
  • J Clin Apher 2021[Jun]; 36 (3): 470-482 PMID33544910show ga
  • The purpose of this systematic review and meta-analysis was to examine clinical outcomes associated with convalescent plasma therapy in COVID-19 patients. We performed a literature search on PubMed, medRxiv, Web of Science, and Scopus to identify studies published up to December 10th, 2020 that examined the efficacy of convalescent plasma treatment for COVID-19. The primary endpoints were mortality, clinical improvement, and hospital length of stay. We screened 859 studies that met the search criteria, performed full-text reviews of 56 articles, and identified 15 articles that fulfilled inclusion criteria for meta-analysis. The odds of mortality were significantly lower in the convalescent plasma group compared to the control group (OR = 0.59 [95% CI = 0.44; 0.78], P < .001), although results from two key randomized controlled trials did not support the mortality benefit. The odds of clinical improvement were significantly higher in the convalescent plasma group compared to the control group (OR = 2.02 [95% CI = 1.54; 2.65], P < .001). There was no difference in hospital length of stay between the convalescent plasma group and the control group (MD = -0.49 days [95% CI = -3.11; 2.12], P = .713). In all, these data indicate that a mortality benefit with convalescent plasma is unclear, although there remain benefits with convalescent plasma therapy for COVID-19.
  • |COVID-19 Serotherapy[MESH]
  • |COVID-19/mortality/*therapy[MESH]
  • |Humans[MESH]
  • |Immunization, Passive/methods[MESH]
  • |Length of Stay[MESH]
  • |Plasma[MESH]
  • |Quality Assurance, Health Care[MESH]
  • |Risk[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box